, a candidate tumor suppressor gene, is abnormally expressed in principal lung cancers. Clin Canc Res 2000, six:2988. Gaur S, Shively JE, Yen Y, Gaur RK: Altered splicing of CEACAM1 in breast cancer: Identification of regulatory sequences that manage splicing of CEACAM1 into extended or quick cytoplasmic domain isoforms. Mol Canc 2008, 7:1?2. Kuespert K, Pils S, Hauck C: CEACAMs: their function in physiology and pathophysiology. Curr Opin Cell Biol 2006, 18:565?71. Nouvion A-L, Oubaha M, LeBlanc S, Davis EC, Jastrow H, Kammerer R, Breton V, Turbide C, Ergun S, Gratton J-P, Beauchemin N: CEACAM1: a essential regulator of vascular permeability. J Cell Sci 2010, 123:4221?230. Ieda J, Yokoyama S, Tamura K, Takifuji K, Hotta T, Matsuda K, Oku Y, Nasu T, Kiriyama S, Yamamoto N, et al: Re-expression of CEACAM1 lengthy cytoplasmic domain isoform is connected with invasion and migration of colorectal cancer. Int J Canc 2011, 129:1351?361. Draberova L, Cerna H, Brodska H, Boubelik M, Watt SM, Stanners CP, Draber P: Soluble isoforms of CEACAM1 containing the A2 domain: elevated serum levels in patients with obstructive jaundice and differences in 3-fucosyl-N-acetyl-lactosamine moiety. Immunology 2000, 101:279?87. Svenberg T, Wahren B, Hammarstrom S: Elevated serum levels of a biliary glycoprotein (BGP I) in patients with liver or biliary tract disease. Clin Exp Immunol 1979, 36:317?25. Ergun S, Kilik N, Ziegeler G, Hansen A, Nollau P, Gotze J, Wurmbach JH, Horst A, Weil J, Fernando M, Wagener C: CEA-related cell adhesion molecule 1: a potent angiogenic factor as well as a significant effector of vascular endothelial development element. Mol Cell 2000, five:311?20.149353-72-0 Chemical name Nittka S, Bohm C, Zentgraf H, Neumaier M: The CEACAM1-mediated apoptosis pathway is activated by CEA and triggers dual cleavage of CEACAM1. Oncogene 2008, 27:3721?728. Tilki D, Singer BB, Shariat SF, Behrend A, Fernando M, Irmak S, Buchner A, Hooper AT, Stief CG, Reich O, Erg S: CEACAM1: A Novel Urinary Marker for Bladder Cancer Detection. Eur Urol 2010, 57:648?54. Ohwada A, Takahashi H, Nagaoka I, Kira S: Biliary glycoprotein mRNA expression is elevated in key lung cancer, in particular in squamous cell carcinoma. Am J Respir Cell Mol Biol 1994, 11:214?20. Singer BB, Scheffrahn I, Heymann R, Sigmundsson K, Kammerer R, Obrink B: Carcinoembryonic antigen-related cell adhesion molecule 1 expression and signaling in human, mouse, and rat leukocytes: proof for replacement of the short cytoplasmic domain isoform by glycosylphosphatidylinositol-linked proteins in human leukocytes. J Immunol 2002, 168:5139?146. Guo J-Q, Yu W-H, Wang H-J, Liu B, Zhu K-X, Zhang Q-H, Zhang T-G, Xu W-H, Wang H-B, Wu H-L, Zhou C-J: Distinct expression patterns of CEACAM1 and its impacts on Angiogenesis in Gastric Nonneoplastic and Neoplastic Lesions.Val-Cit-PAB-MMAE web Ann Surg Oncol 2012, 19:365?74.PMID:24856309 doi:ten.1186/1471-2407-13-359 Cite this short article as: Zhou et al.: Clinical and experimental studies concerning the expression and diagnostic value of carcinoembryonic antigen-related cell adhesion molecule 1 in non-small-cell lung cancer. BMC Cancer 2013 13:359.
OPENCitation: Cell Death and Disease (2013) four, e705; doi:ten.1038/cddis.2013.229 2013 Macmillan Publishers Restricted All rights reserved 2041-4889/nature/cddisCorrespondenceThyroid hormones improve development and counteract apoptosis in human tenocytes isolated from rotator cuff tendonsF Oliva1, AC Berardi2, S Misiti3, CV Falzacappa3, A Iacone2 and N Maffulli*,four,five,Cell Death and Disease (2013) four, e705; doi:10.1038/cddis.20.
